Sun Oct 05 12:11:11 UTC 2025: **Summary:**

The Indian newspaper “The Hindu” reports on the ban of Coldrif cough syrup in Madhya Pradesh, India, following the deaths of at least 14 children from suspected kidney failure in Madhya Pradesh and Rajasthan. Testing revealed the syrup, manufactured by Sresan Pharma in Tamil Nadu, contained dangerously high levels (48.6%) of diethylene glycol (DEG), a toxic industrial solvent. Other states are taking action in response.

**News Article:**

**Coldrif Cough Syrup Banned in Madhya Pradesh After Child Deaths Linked to Toxin**

**NEW DELHI, October 5, 2025** – The Madhya Pradesh government has issued an immediate ban on the sale of Coldrif cough syrup following a tragic series of deaths potentially linked to the medication. At least 14 children in Madhya Pradesh and Rajasthan have died since early September from suspected kidney failure, with initial investigations pointing to Coldrif as the common factor.

Tests conducted by state authorities on samples of the cough syrup, manufactured by Sresan Pharma in Tamil Nadu, revealed alarmingly high levels of diethylene glycol (DEG). The samples contained 48.6% DEG, a toxic industrial solvent known to be fatal even in small doses.

“The presence of such high levels of diethylene glycol in a medication intended for children is deeply concerning,” said a spokesperson for the Madhya Pradesh Ministry of Health. “We have taken swift action to remove Coldrif from shelves and prevent further harm.”

The ban has been implemented across Madhya Pradesh, and other states are reportedly considering similar measures. The incident has sparked a nationwide investigation into the manufacturing processes of Sresan Pharma and the quality control measures in place for pharmaceutical products.

This news comes as “The Hindu” launches a series of newsletters like, “The View From India” focusing on the Indian perspective on world affairs, “First Day First Show” covering cinema and streaming, “Today’s Cache” highlighting top tech stories, “Science For All” demystifying science, “Data Point” analyzing data-driven news, “Health Matters” promoting well-being, and “The Hindu On Books” featuring literary reviews.

Read More